Global Home Global Home  
 
 

 

 

Investor Relations

Oculus Innovative Science is a global healthcare company that designs, manufactures and markets prescription and non-prescription products in 33 countries. The company's products are used to treat patients in advanced wound management, dermatology, women’s health and animal health; addressing the unmet medical needs of these markets, while raising the standard of patient care and lowering overall healthcare costs.  The company's headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. 

Recent Releases

Oct 30, 2014
Oculus Innovative Sciences Receives European CE Mark for New Microcyn®-Based Atopic Dermatitis Hydrogel

Oct 30, 2014
Oculus Innovative Sciences Announces Fiscal Second Quarter 2015 Financial Results and Conference Call

Sep 16, 2014
Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Allowance of Four New Patents for Microcyn® Technology

more »

Forward-Looking Statements
This website contains forward-looking statements based on certain assumptions and expectations. For this purpose, any statements contained in this website that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will," "intends" and similar expressions are intended to identify forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties relating to our product development, success of clinical trials, obtaining the requisite regulatory approvals, market acceptance of our product, our ability to protect our intellectual property and future financial results. For a discussion of other factors that may cause Oculus’ actual results to differ from those projected, expressed or implied by the forward looking statements, please refer to the Company's Registration Statement on Form S-1 as well as other subsequent filings with the Securities and Exchange Commission. We do not undertake, and specifically disclaim any obligation, to revise any forward looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date of such statements.